F.D.A. Panel Recommends Pulling Preterm Birth Drug From the Market

The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.

BY CHRISTINA JEWETT | NYTimes Health | Disclosure

from Blogger https://ift.tt/zco96R4
via SEO Services


About renato.toffanin

Co-founder and Managing Director at ARCHES, I am passionate about helping people increase their potential and showing them better ways to communicate and interact. Particularly interested in promoting sustainable development and inclusive growth, I am involved in the innovation dialogue with policy makers, and industrial and academic actors on the European scene and beyond.
This entry was posted in News Updates and tagged , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.